Efficacy and safety of surgery with curative intent in patients treated with first-line Bevacizumab plus chemotherapy for metastatic colorectal cancer: First beat

被引：0
|
作者：
Kretzschmar, A. [1 ]
Cunningham, D. [2 ]
Berry, S. [3 ]
Rivera, F. [4 ]
Di Bartolomeo, M. [5 ]
Mazier, M. [6 ]
Van Cutsem, E. [7 ]
机构：
[1] Klinikum Berliln, HELIOS, Berlin, Germany
[2] Royal Marsden Hosp, Sutton, Surrey, England
[3] Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[4] Hosp Marques Valdecilla, Santender, Spain
[5] Ist Nazl Tumori, I-20133 Milan, Italy
[6] Parexel, Paris, France
[7] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：I25 / I25
页数：1
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS STANDARD FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: FIRST BEAT
    Van Cutsem, E.
    Berry, S.
    Michael, M.
    Kretzschmar, A.
    Rivera, F.
    DiBartolomeo, M.
    Mazier, M.
    Andre, N.
    Cunningham, D.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
  • [2] Surgery with curative intent in patients (pts) treated with first-line chemotherapy (CT) plus bevacizumab (BEV) for metastatic colorectal cancer (mCRC): First BEAT and NO16966
    Cassidy, J.
    Cunningham, D.
    Berry, S. R.
    Rivera, F.
    Clarke, S. J.
    Kretzschmar, A.
    Diaz-Rubio, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial
    Okines, A.
    Del Puerto, O.
    Cunningham, D.
    Chau, I.
    Van Cutsem, E.
    Saltz, L.
    Cassidy, J.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (07) : 1033 - 1038
  • [4] Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial
    A Okines
    O del Puerto
    D Cunningham
    I Chau
    E Van Cutsem
    L Saltz
    J Cassidy
    [J]. British Journal of Cancer, 2009, 101 : 1033 - 1038
  • [5] Efficacy and safety of bevacizumab with standard first-line fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer: First beat
    Rivera, F.
    Cunningham, D.
    Berry, S.
    Kretzschmar, A.
    Michael, M.
    Dibartolomeo, M.
    Mazier, M.
    Andre, N.
    Van Cutsem, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 17 - 17
  • [6] Optimizing the Efficacy of First-Line Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer
    Shaotang Li
    Pan Dr Chi
    [J]. BioDrugs, 2011, 25 : 43 - 50
  • [7] Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis
    Wang Ming
    Zheng Xiaofeng
    Ruan Xiaojiao
    Ye Bailiang
    Cai Long
    Lin Feizhuan
    Tu Jinfu
    Jiang Feizhao
    Li Shaotang
    [J]. CHINESE MEDICAL JOURNAL, 2014, 127 (03) : 538 - 546
  • [8] Final efficacy results for bevacizumab plus standard first-line chemotherapies in patients with metastatic colorectal cancer: First BEAT
    Berry, S. R.
    Van Cutsem, E.
    Kretzschmar, A.
    Michael, M.
    Rivera, F.
    DiBartolomeo, M.
    Mazier, M. A.
    Andre, N.
    Cunningham, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    [J]. MEDICINE, 2016, 95 (51) : e4531
  • [10] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    M. Ozcelik
    H. Odabas
    O. Ercelep
    S. Yuksel
    A. G. Mert
    D. Aydin
    H. Surmeli
    D. Isik
    S. Isik
    A. Oyman
    B. B. Oven Ustaalioglu
    M. Aliustaoglu
    M. Gumus
    [J]. Clinical and Translational Oncology, 2016, 18 : 617 - 624
12345